Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Cell and Gene Therapy, Biologics, Cancer
Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.
April 2, 2025 -
3 min read
Cancer
The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.
March 25, 2025 -
3 min read
Cancer
Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.
March 5, 2025 -
8 min read
Cancer
How Mimix™ Reference Standards are generated, and how they can support your oncology research.
February 28, 2025 -
7 min read
Cancer
Lentiviral sgRNA CRISPR screening in primary human immune cells.
February 19, 2025 -
2 min read
Cancer
Considerations for engineering a successful knockout cell line generation.
January 17, 2025 -
1 min read
Cancer
Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.
January 15, 2025 -
4 min read
Cancer
Homology-directed repair with a DNA donor oligo: considerations for successful HDR experimental design.
January 14, 2025 -
5 min read
Cancer
Tips on establishing a reliable cell free DNA (cfDNA) workflow from plasma samples.
November 26, 2024 -
6 min read
